Loading...
Neonatal Genetic Delivery of Anti-Respiratory Syncytial Virus (RSV) Antibody by Non-Human Primate-Based Adenoviral Vector to Provide Protection against RSV
Respiratory syncytial virus (RSV) is one of the leading causes of lower respiratory tract infection in infants. Immunoprophylaxis with the anti-RSV monoclonal antibody, palivizumab, reduces the risk for RSV-related hospitalizations, but its use is restricted to high-risk infants due to the high cost...
Na minha lista:
| Udgivet i: | Vaccines (Basel) |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6466083/ https://ncbi.nlm.nih.gov/pubmed/30597977 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines7010003 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|